Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biochem Pharma (BCHE) -- Ignore unavailable to you. Want to Upgrade?

To: JDN who wrote (722)	3/11/2000 11:56:00 AM
From: Aggie	Read Replies (2) \| Respond to of 783

JDN, hello I've been in this stock for over five years now. I'm not leveling specific allegations of any kind - but I find it impossible to believe that a company with this kind of drug portfolio (3TC) and pipeline is performing so poorly. Look at the biotechnology sector right now, and think about rising tides and the rest of the boats. Where has this stock gone, and what is the response every time there is a positive press release? Not positive - although there are unexplained spikes with no apparent relation to news events. The 200 day MA has been essentially flat since July '96. Does it make you wonder? Everytime there is a negative comment on this thread and others devoted to BCHE, it's generally responded to with a "happiness is just around the corner" story from, I guess, other shareholders. So....I'm outta this one as soon as possible. There are much better biotech fish to fry right now. BCHE remains in my book a dismal under-performer. Best of luck to you in your continued investing. I hope that BCHE turns itself around for you. Regards, Aggie